Alembic Pharmaceuticals has informed that the Company has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (US FDA) for the inspection carried out by them at the Formulation Facility at Panelav during the period from 12th March, 2018 to 20th March, 2018.
The above information is a part of company’s filings submitted to BSE.